Renal safety of ibandronate in patients with renal deterioration and multiple myeloma

被引：0
|
作者：
Raoul, R
Henrich, DM
Hoffmann, M
Ullmann, M
Honecker, A
Nagel, D
Uppenkamp, M
机构：
[1] Klinikum Stadt Ludwigshafen gGmbH, Med Klin A, Ludwigshafen, Germany
[2] Klinikum Stadt Ludwigshafen gGmbH, Inst Klin Chem, Ludwigshafen, Germany
[3] MDS Pharma Serv, Zurich, Switzerland
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：V100 / V101
页数：2
相关论文
共 50 条
  • [31] Evaluation of the Safety and Efficacy of Denosumab in Patients With Multiple Myeloma and Severe Renal Impairment
    Terpos, Evangelos
    Ntanasis-Stathopoulos, Ioannis
    Kyriakou, Charalampia
    Tan, Carlyn
    Abildgaard, Niels
    Delforge, Michel
    Fantl, Dorotea
    Usmani, Saad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S198 - S199
  • [32] Renal safety of intravenous ibandronate:: Clinical evidence
    Diel, I
    Body, JJ
    Bergström, B
    CANCER TREATMENT REVIEWS, 2005, 31 : S48 - S48
  • [33] Renal safety of intermittent intravenous ibandronate injection
    Adami, S
    Body, J
    Pecherstorfer, M
    Schimmer, RC
    Bauss, F
    T Pfister, T
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 455 - 455
  • [34] Renal safety and tolerability of ibandronate in clinical practice
    Seraphin, J.
    Schuetz, F.
    Nusch, A.
    Meden, H.
    CANCER TREATMENT REVIEWS, 2006, 32 : S38 - S38
  • [35] A STUDY OF RENAL FUNCTION IN PATIENTS WITH MULTIPLE MYELOMA
    ARMSTRONG, JB
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1950, 219 (05): : 488 - 493
  • [36] Thalidomide in patients with multiple myeloma and renal failure
    Fakhouri, F
    Guerraoui, H
    Presne, C
    Peltier, J
    Delarue, R
    Muret, P
    Knebelmann, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (01) : 96 - 97
  • [37] Treatment of multiple myeloma patients with renal disease
    Weisel, K. C.
    ONKOLOGIE, 2010, 33 : 10 - 10
  • [38] Renal deterioration in multiple sclerosis patients with neurovesical dysfunction
    Fletcher, Sophie G.
    Dillon, Benjamin E.
    Gilchrist, Alienor S.
    Haverkorn, Rashel M.
    Yan, Jingsheng
    Frohman, Elliot M.
    Lemack, Gary E.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (09) : 1169 - 1174
  • [39] Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: A retrospective medical records review
    Weide, Rudolf
    Koeppler, Hubert
    Antras, Lucia
    Smith, Michael
    Chang, Eva
    Green, Jesse
    Wintfeld, Neil
    Neary, Maureen P.
    Duh, Mei Sheng
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2010, 6 (01) : 31 - 35
  • [40] Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment
    Bridoux, Frank
    Chen, Nianhang
    Moreau, Stephane
    Arnulf, Bertrand
    Moumas, Eric
    Abraham, Julie
    Desport, Estelle
    Jaccard, Arnaud
    Fermand, Jean Paul
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (01) : 173 - 182
12345